Flow Robotics established its North American Subsidiary, Flow Robotics, Inc., with operations in Princeton, NJ. The company’s first product, the flowbot® ONE, is designed to transform how liquid handling responsibilities are performed in the laboratory. The robot will be showcased for the first time in the U.S. at the SLAS 2021 Americas Sample Management Hybrid Symposium September 9-10, 2021 in La Jolla, CA.
The flowbot ONE helps labs achieve a more sustainable setup by taking over many of the repetitive and burdensome manual pipetting tasks. Flow Robotics estimates that about half of medical lab technicians carry out the same arm movements for at least a quarter of their working day. The American Society for Clinical Pathology found that 85 percent of laboratory professionals suffer from burnout.
Flexible ease of use and adaptability to perform multiple tasks
Unlike other automated liquid handling robots, flowbot ONE does not require advanced programming skills so just about anyone can set up a procedure. The robot also has the ability to integrate to devices positioned on the deck or external to the system. “We continue to see the need for more flexibility in robotics automation in clinical and research labs across the world,” said Craig Cardella, Vice President and General Manager for Flow Robotics’ new North American division.
Helps in fight against covid-19
More than 600,000 COVID-19 tests are being prepared each month on a flowbot ONE in Europe. The robots pipette the live virus, handling several samples simultaneously, all working from a predefined pipetting pattern. Since May 2020, the flowbot One has played an integral role in the fight against CO VID-19.
Significant increases in lab productivity
The flowbot ONE has helped to increase lab productivity by 40 percent and reduced the time patients need to wait for results by 30 percent. Nordic Bioscience, a biomarker powerhouse that develops novel biomarkers and performs clinical trials, automated their clinical lab equipment. Hands-on lab time was reduced from 2 hours and 15 minutes to 20 minutes when running up to 8 biomarkers simultaneously.